Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 USD | -2.38% | -13.38% | +56.69% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 26.49 | 14.24 | 10.73 | 21.32 | - | - |
Enterprise Value (EV) 1 | 26.49 | 14.24 | 10.73 | 21.32 | 21.32 | 21.32 |
P/E ratio | -3.78 x | -1.14 x | -0.95 x | -1.49 x | -1.53 x | -2.62 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | 1.86 x |
EV / Revenue | - | - | - | - | - | 1.86 x |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | -17,024,599 x | - | - | - | - | - |
FCF Yield | -0% | - | - | - | - | - |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 10,768 | 11,674 | 13,666 | 17,334 | - | - |
Reference price 2 | 2.460 | 1.220 | 0.7850 | 1.230 | 1.230 | 1.230 |
Announcement Date | 4/14/22 | 3/22/23 | 4/5/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | 11.48 |
EBITDA | - | - | - | - | - | - | - |
EBIT 1 | - | -5.587 | -13.55 | -13.3 | -14.08 | -16.09 | -9.726 |
Operating Margin | - | - | - | - | - | - | -84.76% |
Earnings before Tax (EBT) 1 | - | -4.041 | -12.34 | -11.28 | -13.9 | -14.83 | -9.726 |
Net income 1 | -2.828 | -4.041 | -12.34 | -11.28 | -14.08 | -16.09 | -9.726 |
Net margin | - | - | - | - | - | - | -84.76% |
EPS 2 | -1.540 | -0.6500 | -1.070 | -0.8300 | -0.8250 | -0.8050 | -0.4700 |
Free Cash Flow | - | -1.556 | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 8/10/21 | 4/14/22 | 3/22/23 | 4/5/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -0.88 | -1.26 | -3.264 | -3.59 | -3.319 | -3.379 | -3.641 | -3.477 | -2.897 | -3.287 | -3.186 | -3.304 | -3.565 | -3.848 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -0.89 | -0.989 | -2.715 | -3.481 | -2.994 | -3.15 | -3.889 | - | 0.784 | -2.95 | -3.186 | -3.304 | -3.565 | -3.848 |
Net income 1 | -0.89 | -0.989 | -2.715 | -3.481 | -2.994 | -3.15 | -3.889 | -5.225 | 0.784 | -2.95 | -3.186 | -3.304 | -3.565 | -3.848 |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -0.1500 | -0.0700 | -0.2400 | -0.3100 | -0.2500 | -0.2700 | -0.3300 | -0.4400 | 0.1000 | -0.1600 | -0.2000 | -0.2100 | -0.2000 | -0.2150 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 12/1/22 | 4/14/22 | 5/31/22 | 8/31/22 | 12/1/22 | 3/22/23 | 6/1/23 | 8/16/23 | 11/28/23 | 4/5/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow | - | -1.56 | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | 0.02 | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - |
Announcement Date | 8/10/21 | 4/14/22 | 3/22/23 | 4/5/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.69% | 21.32M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- NRSN Stock
- Financials NeuroSense Therapeutics Ltd.